002099.SZ
海翔药业
SZSE · Healthcare · C 制造业 · CN
CNY 5.05
−3.63%Margins
Gross margin
25.0%
EBITDA margin
13.9%
EBIT margin
-3.8%
Net margin
-4.0%
FCF margin
-8.2%
-1.5%
Return on equity
-1.0%
Return on assets
-1.2%
Return on invested capital
0.26x
Asset turnover
-CNY 87.8M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026